Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Demographic, neurocognitive, disease impact, and social characteristics of patients served by embedded neuropsychological services in an adult sickle cell clinic

View Full Paper
Ask AI
Bookmark
Share

Authors

BBBrooke Benowitz

Discussion

Loading...

Member takes

Overview

Observational analysis found neurocognitive and SCD impact characteristics in adults, suggesting access to neuropsychological evaluation can aid patient care.

Key Points

  • Cognitive performance and self-reported impact of sickle cell disease were within normal limits, indicating potential for better patient management.
  • Average cognitive performance was noted, with significant recommendations for social work intervention and psychotherapy after neuropsychological evaluation.
  • Multivariate analyses were conducted to compare cognitive performance and SCD impact by insurance type, highlighting substantial effect sizes despite power limitations.
  • Findings suggest that access to neuropsychological evaluation is essential for enhancing support services for adult patients with sickle cell disease.

Cite This Study

Brooke Benowitz (2025) studied this question.

synapsesocial.com/papers/69362f7d4fa91c937236e4abhttps://doi.org/10.1182/blood-2025-1187
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evaluating the efficacy of brief neurocognitive assessments in adults and adolescents with sickle cell disease2025
  2. 2Description of neurocognition in adult sickle cell disease patients using the NIH toolbox2025
  3. 3Social isolation and patient-reported and healthcare utilization in adults with sickle cell disease2025
  4. 4Implementation of a comprehensive sickle cell center leads to improved access to care and decreased acute care use2026
  5. 5Transportation barriers and Medicaid's transportation service use in sickle cell disease: A mixed methods study in Wisconsin2025